The Significance of Exposure to Pregestational Type 2 Diabetes in Utero on Fetal Renal Size and Subcutaneous Fat Thickness

Objectives. To determine the relationship between exposure to pregestational type 2 diabetes (T2D) and renal size and subcutaneous fat thickness in fetuses during routine obstetrical ultrasound. Methods. This was a case-control study (January 1, 2019 to December 31, 2019). Routine obstetrical ultras...

Full description

Saved in:
Bibliographic Details
Main Authors: Christy L. Pylypjuk, Chelsea Day, Yasmine ElSalakawy, Gregory J. Reid
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2022/3573963
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554659331440640
author Christy L. Pylypjuk
Chelsea Day
Yasmine ElSalakawy
Gregory J. Reid
author_facet Christy L. Pylypjuk
Chelsea Day
Yasmine ElSalakawy
Gregory J. Reid
author_sort Christy L. Pylypjuk
collection DOAJ
description Objectives. To determine the relationship between exposure to pregestational type 2 diabetes (T2D) and renal size and subcutaneous fat thickness in fetuses during routine obstetrical ultrasound. Methods. This was a case-control study (January 1, 2019 to December 31, 2019). Routine obstetrical ultrasounds performed between 18 and 22 weeks’ gestation at a tertiary-care fetal assessment unit were reviewed. “Cases” comprised ultrasounds of fetuses exposed to pregestational T2D in utero. The control group was assembled from ultrasounds of healthy controls. Postprocessing measurements of fetal renal size and abdominal wall thickness from stored images were performed by two independent observers, and findings were compared between groups. Results. There were 54 cases and 428 ultrasounds of healthy controls. The mean maternal age of cases was 32.1 years (SD 6.2) compared to 33.2 years (SD 5.3) for healthy controls, and the majority of ultrasounds were performed in multiparous patients (83%). At the 18 to 22 week ultrasound, there was a significant reduction in renal size amongst fetuses exposed to maternal T2D in utero compared to controls; among cases, the mean renal width was 8.0 mm (95% CI 7.8–8.1) compared to 11.4 mm (95% CI 10.6–12.7) in controls (p<0.0001); the mean renal thickness among cases was 8.1 mm (95% CI 7.9–8.2) compared to 11.5 mm (95% CI 10.7–12.9) in controls (p=0.001). There was no obvious difference in estimated fetal weight between groups, yet fetuses exposed to maternal T2D had increased subcutaneous abdominal wall fat thickness at this early gestational age (p=0.008). Conclusions. Fetal renal size in cases exposed to pregestational T2D is significantly smaller compared to controls, and subcutaneous abdominal wall fat is significantly thicker. Given emerging evidence about the developmental origins of disease, further study is needed to correlate the association between fetal renal size and fat distribution in the fetus and the long-term risk of chronic renal disease and diabetes in these offspring.
format Article
id doaj-art-ba4452fd587043cb833ee6152475a948
institution Kabale University
issn 2090-2158
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-ba4452fd587043cb833ee6152475a9482025-02-03T05:51:01ZengWileyInternational Journal of Nephrology2090-21582022-01-01202210.1155/2022/3573963The Significance of Exposure to Pregestational Type 2 Diabetes in Utero on Fetal Renal Size and Subcutaneous Fat ThicknessChristy L. Pylypjuk0Chelsea Day1Yasmine ElSalakawy2Gregory J. Reid3Department of Obstetrics, Gynecology and Reproductive SciencesDepartment of Obstetrics, Gynecology and Reproductive SciencesDepartment of Obstetrics, Gynecology and Reproductive SciencesDepartment of Obstetrics, Gynecology and Reproductive SciencesObjectives. To determine the relationship between exposure to pregestational type 2 diabetes (T2D) and renal size and subcutaneous fat thickness in fetuses during routine obstetrical ultrasound. Methods. This was a case-control study (January 1, 2019 to December 31, 2019). Routine obstetrical ultrasounds performed between 18 and 22 weeks’ gestation at a tertiary-care fetal assessment unit were reviewed. “Cases” comprised ultrasounds of fetuses exposed to pregestational T2D in utero. The control group was assembled from ultrasounds of healthy controls. Postprocessing measurements of fetal renal size and abdominal wall thickness from stored images were performed by two independent observers, and findings were compared between groups. Results. There were 54 cases and 428 ultrasounds of healthy controls. The mean maternal age of cases was 32.1 years (SD 6.2) compared to 33.2 years (SD 5.3) for healthy controls, and the majority of ultrasounds were performed in multiparous patients (83%). At the 18 to 22 week ultrasound, there was a significant reduction in renal size amongst fetuses exposed to maternal T2D in utero compared to controls; among cases, the mean renal width was 8.0 mm (95% CI 7.8–8.1) compared to 11.4 mm (95% CI 10.6–12.7) in controls (p<0.0001); the mean renal thickness among cases was 8.1 mm (95% CI 7.9–8.2) compared to 11.5 mm (95% CI 10.7–12.9) in controls (p=0.001). There was no obvious difference in estimated fetal weight between groups, yet fetuses exposed to maternal T2D had increased subcutaneous abdominal wall fat thickness at this early gestational age (p=0.008). Conclusions. Fetal renal size in cases exposed to pregestational T2D is significantly smaller compared to controls, and subcutaneous abdominal wall fat is significantly thicker. Given emerging evidence about the developmental origins of disease, further study is needed to correlate the association between fetal renal size and fat distribution in the fetus and the long-term risk of chronic renal disease and diabetes in these offspring.http://dx.doi.org/10.1155/2022/3573963
spellingShingle Christy L. Pylypjuk
Chelsea Day
Yasmine ElSalakawy
Gregory J. Reid
The Significance of Exposure to Pregestational Type 2 Diabetes in Utero on Fetal Renal Size and Subcutaneous Fat Thickness
International Journal of Nephrology
title The Significance of Exposure to Pregestational Type 2 Diabetes in Utero on Fetal Renal Size and Subcutaneous Fat Thickness
title_full The Significance of Exposure to Pregestational Type 2 Diabetes in Utero on Fetal Renal Size and Subcutaneous Fat Thickness
title_fullStr The Significance of Exposure to Pregestational Type 2 Diabetes in Utero on Fetal Renal Size and Subcutaneous Fat Thickness
title_full_unstemmed The Significance of Exposure to Pregestational Type 2 Diabetes in Utero on Fetal Renal Size and Subcutaneous Fat Thickness
title_short The Significance of Exposure to Pregestational Type 2 Diabetes in Utero on Fetal Renal Size and Subcutaneous Fat Thickness
title_sort significance of exposure to pregestational type 2 diabetes in utero on fetal renal size and subcutaneous fat thickness
url http://dx.doi.org/10.1155/2022/3573963
work_keys_str_mv AT christylpylypjuk thesignificanceofexposuretopregestationaltype2diabetesinuteroonfetalrenalsizeandsubcutaneousfatthickness
AT chelseaday thesignificanceofexposuretopregestationaltype2diabetesinuteroonfetalrenalsizeandsubcutaneousfatthickness
AT yasmineelsalakawy thesignificanceofexposuretopregestationaltype2diabetesinuteroonfetalrenalsizeandsubcutaneousfatthickness
AT gregoryjreid thesignificanceofexposuretopregestationaltype2diabetesinuteroonfetalrenalsizeandsubcutaneousfatthickness
AT christylpylypjuk significanceofexposuretopregestationaltype2diabetesinuteroonfetalrenalsizeandsubcutaneousfatthickness
AT chelseaday significanceofexposuretopregestationaltype2diabetesinuteroonfetalrenalsizeandsubcutaneousfatthickness
AT yasmineelsalakawy significanceofexposuretopregestationaltype2diabetesinuteroonfetalrenalsizeandsubcutaneousfatthickness
AT gregoryjreid significanceofexposuretopregestationaltype2diabetesinuteroonfetalrenalsizeandsubcutaneousfatthickness